drugset / Trial / NCT02058537
Bethanechol for Eosinophilic Esophagitis
NaSingle-groupOpen-labelTreatment
Summary
The primary goals of this study are to ease the symptoms of patients with Eosinophilic Esophagitis (EoE) and to test the effectiveness of the drug bethanechol in relieving those symptoms.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-07
- Completion
- 2014-07
Outcome
Outcome not reported
Stopped: “Initial PI left, study not continued”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bethanechol | Small molecule | 25 mg | Oral |